5 January 2024 · Interactions with apixaban, dabigatran, edoxaban or rivaroxaban can result in increased risks of a bleed or thrombosis. We advise on management options.

5 January 2024 · It is important to understand the risks, mechanisms of interactions and actions to take when prescribing medicines with DOACs.

20 September 2023 · Advice on risks related to use of small volume (less than 3mL) intramuscular (IM) injections in people on oral anticoagulants (for example, DOACs, warfarin)

19 December 2022 · A number of resources are available to support the safe use of high-risk medicines. Healthcare professionals should ensure they are available for their patients

2 November 2021 · Warfarin is the preferred choice during breastfeeding; rivaroxaban or dabigatran may also be used. Recommendations apply to full term and healthy infants.